Skip to main content
. 2023 Jan 18;4(3):e140–e148. doi: 10.1016/S2666-5247(22)00337-8

Figure 2.

Figure 2

Local and systemic reactions following ABNCoV2 vaccination

(A) Related solicited local adverse events. (B) Related solicited systemic adverse events. Data represent the proportion of participants who had an adverse event of the indicated severity. The highest severity grade is shown in case there were multiple episodes of a given adverse event per participant. ABNCoV2 dose and vaccine formulation (with or without MF59) are indicated on the right side.